179 related articles for article (PubMed ID: 11867828)
1. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Thorax; 2002 Mar; 57(3):237-41. PubMed ID: 11867828
[TBL] [Abstract][Full Text] [Related]
2. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Eur Respir J; 2000 Jan; 15(1):68-74. PubMed ID: 10678623
[TBL] [Abstract][Full Text] [Related]
3. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma.
Wilson SJ; Wallin A; Della-Cioppa G; Sandström T; Holgate ST
Am J Respir Crit Care Med; 2001 Sep; 164(6):1047-52. PubMed ID: 11587995
[TBL] [Abstract][Full Text] [Related]
4. Effects of budesonide and formoterol on eosinophil activation induced by human lung fibroblasts.
Spoelstra FM; Kauffman HF; Hovenga H; Noordhoek JA; de Monchy JG; Postma DS
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1229-34. PubMed ID: 11029322
[TBL] [Abstract][Full Text] [Related]
5. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells.
Korn SH; Jerre A; Brattsand R
Eur Respir J; 2001 Jun; 17(6):1070-7. PubMed ID: 11491146
[TBL] [Abstract][Full Text] [Related]
6. Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol.
Todorova L; Gürcan E; Miller-Larsson A; Westergren-Thorsson G
Am J Respir Cell Mol Biol; 2006 Jan; 34(1):92-100. PubMed ID: 16166747
[TBL] [Abstract][Full Text] [Related]
7. Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts.
Todorova L; Gürcan E; Westergren-Thorsson G; Miller-Larsson A
Respir Med; 2009 Nov; 103(11):1755-63. PubMed ID: 19375904
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor.
Lovén J; Svitacheva N; Jerre A; Miller-Larsson A; Korn SH
Eur Respir J; 2007 Nov; 30(5):848-56. PubMed ID: 17596271
[TBL] [Abstract][Full Text] [Related]
9. Budesonide and formoterol reduce early innate anti-viral immune responses in vitro.
Davies JM; Carroll ML; Li H; Poh AM; Kirkegard D; Towers M; Upham JW
PLoS One; 2011; 6(11):e27898. PubMed ID: 22125636
[TBL] [Abstract][Full Text] [Related]
10. Procaterol potentiates the anti-inflammatory activity of budesonide on eosinophil adhesion to lung fibroblasts.
Yoshida N; Muraguchi M; Kamata M; Ikezono K; Mori T
Int Arch Allergy Immunol; 2009; 150(4):352-8. PubMed ID: 19571567
[TBL] [Abstract][Full Text] [Related]
11. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
[TBL] [Abstract][Full Text] [Related]
12. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages.
Donnelly LE; Tudhope SJ; Fenwick PS; Barnes PJ
Eur Respir J; 2010 Jul; 36(1):178-86. PubMed ID: 19926732
[TBL] [Abstract][Full Text] [Related]
13. Fast beneficial systemic anti-inflammatory effects of inhaled budesonide and formoterol on circulating lymphocytes in asthma.
Rüdiger JJ; Gencay M; Yang JQ; Bihl M; Tamm M; Roth M
Respirology; 2013 Jul; 18(5):840-7. PubMed ID: 23617551
[TBL] [Abstract][Full Text] [Related]
14. Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells.
Strandberg K; Palmberg L; Larsson K
J Asthma; 2008 Apr; 45(3):201-3. PubMed ID: 18415826
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide.
Heuck C; Heickendorff L; Wolthers OD
Arch Dis Child; 2000 Oct; 83(4):334-9. PubMed ID: 10999872
[TBL] [Abstract][Full Text] [Related]
16. Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium.
Persdotter S; Lindahl M; Malm-Erjefalt M; von Wachenfeldt K; Korn SH; Stevens T; Miller-Larsson A
Int Arch Allergy Immunol; 2007; 143(3):201-10. PubMed ID: 17290146
[TBL] [Abstract][Full Text] [Related]
17. Effects of beta2-agonists and budesonide on interleukin-1beta and leukotriene B4 secretion: studies of human monocytes and alveolar macrophages.
Zetterlund A; Linden M; Larsson K
J Asthma; 1998; 35(7):565-73. PubMed ID: 9777883
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological modulation of the bradykinin-induced differentiation of human lung fibroblasts: effects of budesonide and formoterol.
Sabatini F; Petecchia L; Usai C; Silvestri M; Rossi GA; Miller-Larsson A; Ricciardolo FL
J Asthma; 2012 Dec; 49(10):1004-11. PubMed ID: 23088211
[TBL] [Abstract][Full Text] [Related]
19. Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses.
Bochkov YA; Busse WW; Brockman-Schneider RA; Evans MD; Jarjour NN; McCrae C; Miller-Larsson A; Gern JE
Respir Res; 2013 Oct; 14(1):98. PubMed ID: 24219422
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts.
Descalzi D; Folli C; Nicolini G; Riccio AM; Gamalero C; Scordamaglia F; Canonica GW
Allergy; 2008 Apr; 63(4):432-7. PubMed ID: 18076728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
